---
title: "BioNexus Gene Lab Corp. (BGLC.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BGLC.US.md"
symbol: "BGLC.US"
name: "BioNexus Gene Lab Corp."
industry: "工业设备分销商"
---

# BioNexus Gene Lab Corp. (BGLC.US)

| Item | Detail |
|------|--------|
| Industry | 工业设备分销商 |
| Location | 美股市场 |
| Website | [www.bionexusgenelab.com](https://www.bionexusgenelab.com) |

## Company Profile

BioNexus Gene Lab Corp. 通过其子公司，专注于在马来西亚、印度尼西亚、越南及其他东南亚国家销售用于工业、医疗、家电、航空、汽车、机械和电子产品制造的化学原材料。该公司通过三个部门运营：工业化学品贸易；基因筛查服务提供；以及投资控股。它提供多种化学原材料产品，包括聚酯树脂 SHCP 268，这是一种触变性、快速固化的不饱和聚酯树脂，适合作为通用树脂；聚酯树脂 9509，一种用于生产海洋船只和水滑梯的通用材料；以及聚酯树脂 2802，作为拉挤工艺中的一个组成部分。该公司的产品用于生产各种成品，如扶手、工作台面以及汽车和航空零部件；医院、实验室和工业洁净室的面板；以及用于制造的...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-26T04:30:12.000Z

**Overall: C (0.48)**

**Industry**: Trading Companies and Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 51 / 63 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.22% |  |
| Net Profit YoY | -143.94% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.88 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5.97M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 9.47M |  |


**Multi Score**: C

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -28.35% | E |
| Profit Margin | -24.27% | E |
| Gross Margin | 14.85% | D |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.22% | C |
| Net Profit YoY | -143.94% | E |
| Total Assets YoY | -30.68% | E |
| Net Assets YoY | -27.40% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -412.09% | D |
| OCF YoY | 2.22% | C |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.02 | A |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 10.56% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - BioNexus Gene Lab Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-28.35%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-24.27%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "14.85%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "2.22%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-143.94%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-30.68%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-27.40%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-412.09%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "2.22%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.02",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "10.56%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Marubeni Corporation (US.MARUY) | B | B | B | D | B | B |
| 02 | 固安捷 (US.GWW) | A | C | A | C | B | B |
| 03 | 快扣 (US.FAST) | A | B | A | A | B | B |
| 04 | Ferguson Enterprises (US.FERG) | B | C | A | D | B | B |
| 05 | FTAI Aviation (US.FTAI) | A | A | B | E | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.57 | 44/58 | - | - | - |
| PB | 0.87 | 8/58 | 1.34 | 1.14 | 0.64 |
| PS (TTM) | 0.62 | 16/58 | 1.03 | 0.85 | 0.56 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/BGLC.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BGLC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BGLC.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.